About Corentec
Corentec is a company based in Irvine (United States) founded in 2000. The company has 172 employees. Corentec has completed 1 acquisition, including Woosung Pharmaceutical. Corentec offers products and services including Bencox Hip System, Benfix Hip System, Lospa Knee System, Exult Knee System, and Coralis Shoulder System. Corentec operates in a competitive market with competitors including Globus Medical, RTI Surgical, Implanet, Lima Corporate and ExacTech, among others.
- Headquarter Irvine, United States
- Employees 172
- Stage Public
- SectorsHealthcare
- Website corentec.com
- Social LinkedIn Facebook
- Legal Name Corentec Co., Ltd.
- Annual Revenue$69.54 M (USD)17.33as on Dec 31, 2025
- Net Profit$4.33 M (USD)0as on Dec 31, 2025
- EBITDA$10.03 M (USD)83.26as on Dec 31, 2025
- Investors
- Employee Count172
- Investments & Acquisitions
Products & Services of Corentec
Corentec offers a comprehensive portfolio of products and services, including Bencox Hip System, Benfix Hip System, Lospa Knee System, Exult Knee System, and Coralis Shoulder System.
Artificial hip joint device for orthopedic surgery.
Alternative hip joint system for medical applications.
Knee joint replacement device for patient mobility.
Advanced knee system for joint reconstruction.
Shoulder joint device for orthopedic repairs.
Spinal device for joint and support functions.
Anchor for sports injury repairs and joint stability.
Funding Insights of Corentec
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Corentec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2010 | – | Debt – Venture | – | – |
1 investors in total: 1 institutional.
Investors in Corentec
Corentec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Stonebridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech and life sciences focused VC & PE firm | – | stonebridge.co.kr | Seoul, South Korea |
Investor details for Corentec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Corentec
6 people are tracked at Corentec (5 in leadership, 1 in team); the tracked headcount is 172.
| Name | Role | Group |
|---|---|---|
Sungtaek Hong | CEO | Leadership |
Gyeong-Hun Seon | Co-Chief Executive Officer | Leadership |
Brian May | VP Product Development & Strategy | Leadership |
Mark Price | Vice President Marketing And Medical Education | Leadership |
Michael Son | Executive Vice President | Leadership |
Leah Sherman | Lead Project Engineer | Team |
Complete people profiles for Corentec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Corentec
Corentec is a publicly listed company on the KRX with ticker symbol 104540 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Mar 2013
- Listed onKRX: 104540
- Listed entityCorentec Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7104540000
- Share price5,370.00 KRW (-9.44% on the day) · 2026-10-12
- Market capitalisation79,505,944,986.00 KRW
- Price to earnings12.2
- EPS (diluted, trailing year)438.85 KRW
- Volume (last session)153,537
Financials of Corentec
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 100.43B KRW | 6.26B KRW | 14.49B KRW |
| 2024 | 85.59B KRW | -2.58B KRW | 7.91B KRW |
| 2023 | 92.05B KRW | 4.06B KRW | 11.99B KRW |
| 2022 | 63.91B KRW | 1.78B KRW | 9.70B KRW |
| 2021 | 44.63B KRW | 763.9M KRW | 7.09B KRW |
Detailed financial statements for Corentec
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Corentec
Corentec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Woosung Pharmaceutical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Drugs for multiple therapeutic areas are manufactured through R&D focus. | woosung-pharma.com | Suwon-si, South Korea | 2015 | May 2023 | $5.43M |
Complete acquisition details for Corentec
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Corentec
4 dated milestones of Corentec across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Corentec is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Woosung Pharmaceutical.
Competitors of Corentec
Corentec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globus Medical, RTI Surgical, Implanet, Lima Corporate and ExacTech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| globusmedical.com | 2003 | Audubon, United States | $110M | 1,542 | Developer of minimally invasive products for musculoskeletal procedures | |
| rtix.com | 1992 | Alachua, United States | – | 2,232 | Develops innovative technologies for spinal and orthopedic implants and instruments. | |
| implanet.com | 2007 | Martillac, France | $9.57M | – | Orthopedic implants are developed for spine, knee, and arthroscopy procedures. | |
| limacorporate.com | 1945 | Udine, Italy | – | – | Large joint primary and revision 3D printed implants for hip and knee, and fixation devices | |
| exac.com | 1985 | Florida, Puerto Rico | – | 555 | Implants, instruments, and technologies for joint replacement are developed. | |
| djoglobal.com | 1978 | Carlsbad, United States | $1M | 2,080 | Orthopedic devices and pain management products are developed. | |
| omnils.com | 1999 | Taunton, United States | $33.37M | – | Hip and knee orthopedic implants are engineered, manufactured, and distributed. | |
| medacta.com | 1999 | Lane Cove, Australia | – | – | Orthopedic implants and surgical instruments are manufactured for joint surgeries. | |
| auxein.com | 1996 | Delhi, India | – | 348 | Orthopedic products portfolio is developed by Auxein Medical. | |
| renovis-surgical.com | 2009 | Redlands, United States | $10.74M | 47 | Orthopedic implants are provided to surgeons and hospitals. |
Detailed competitors of Corentec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Corentec
The website of Corentec (corentec.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▼ 2.1% vs previous month
Latest news on Corentec
Complete news archive for Corentec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Corentec
10 companies that operate in the same segment as Corentec (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Corentec
Corentec was founded in 2000 and raised its 1st funding round 10 years after it was founded.
Corentec is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Sungtaek Hong is the current CEO of Corentec.
Corentec has 172 employees.
Annual revenue of Corentec is $69.54M as on Dec 31, 2025.
Corentec was established in 2000 and is based in Irvine, United States. Orthopedic implants are designed, manufactured, and marketed by the company within the hip, knee, and spinal sectors. Ownership of brands including Bencox for hip, Lospa for knee, and Lospa IS for spinal fixation is held. The product range encompasses acetabular systems, screw systems, cage systems, femoral components, and modular knee systems.
Corentec's top competitors include Globus Medical, ExacTech and Implanet.
Corentec offers Bencox Hip System, Benfix Hip System, Lospa Knee System, Exult Knee System, and 3 more products and services.
Yes, Corentec is publicly traded on KRX under the ticker symbol 104540.
Corentec has made 1 acquisition, including Woosung Pharmaceutical.
Corentec has 1 investor. Key investors include Stonebridge Capital.
Corentec operates through Corentec America, Inc..